European stocks were little changed, heading for a third month of gains, as a report showed unemployment in the euro area fell from a record high. U.S. index futures rose, while Asian shares were also little changed.
Kesko Oyj, Finland�� biggest publicly traded retailer, rallied 9 percent. Banca Monte dei Paschi di Siena SpA (BMPS) added 2 percent as Italy�� third-largest lender set out a plan to return to profit after cutting costs and raising capital as part of its restructuring plan. Speedy Hire Plc sank the most since 2009 after the construction-equipment leasing company said it found evidence of false accounting at one of its units.
The Stoxx Europe 600 Index climbed 0.1 percent to 325.36 at 11:37 a.m. in London, trading near its highest level since May 2008. The gauge has risen 0.9 percent in November. Standard & Poor�� 500 Index futures advanced 0.2 percent today following the Thanksgiving holiday yesterday. The U.S. stock market will close early at 1 p.m. New York time. The MSCI Asia Pacific Index increased 0.1 percent.
Top 10 Cheap Stocks To Buy Right Now: Baxter International Inc. (BAX)
Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It operates in three segments: BioScience, Medication Delivery, and Renal. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines. The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs; intravenous nutrition products; infusion pumps; and inhalation anesthetics. It also offers products and services related to pha rmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease or irreversible kidney failure. It manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes product for hemodialysis, which is conducted in a hospital or clinic. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors? offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is based in Deerfield, Illinois.
Advisors' Opinion:- [By George Acs]
Baxter International (BAX) recently beat earnings estimates, but wasn't shown too much love from investors for its efforts. I look at it as an opportunity to repurchase shares at a price lower than I would have expected, although still higher than the $70 at which my most recent shares were assigned. In this case, with a dividend due early in September, I might consider a September 17, 2013 option contract, even though weekly and extended weekly options are available.
- [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]
Baxter International Inc.(BAX) said it plans to create separate, independent health-care companies, one focused on developing and marketing biopharmaceuticals and the other on medical products. Shares climbed 11% to $77.90 premarket.
Top 10 Asian Companies To Buy For 2014: Titan Pharmaceuticals Inc (TTNP.OB)
Titan Pharmaceuticals, Inc., incorporated in February 1992, is a biopharmaceutical company developing therapeutics primarily for the treatment of central nervous system (CNS) disorders. The Company is focused primarily on clinical development of products that include Probuphine for the treatment of opioid addiction; Iloperidone: for the treatment of schizophrenia and related psychotic disorders, and Spheramine for the treatment of advanced Parkinson�� disease. Titan Pharmaceuticals is directly developing its product candidates and also utilizing corporate partnerships, including a collaboration with Bayer Schering Pharma AG, Germany (Bayer Schering) for the development of Spheramine to treat Parkinson�� disease, and Vanda Pharmaceuticals, Inc. (Vanda) for the development of iloperidone for the treatment of schizophrenia and related psychotic disorders.
Probuphine
Probuphine is the first product to utilize the Company�� ProNeura long-ter m drug delivery technology. Probuphine is designed to provide continuous, long-term therapeutic levels of the drug buprenorphine, an approved agent for the treatment of opioid addiction. In December 2007, the Company completed enrollment in a randomized, double-blind, placebo-controlled, multi-center Phase III clinical study of Probuphine in the treatment of opioid addiction. This 150 patient study, which is being conducted in the United States, will evaluate the safety and effectiveness of treatment with Probuphine versus placebo in reducing opioid addiction over 24 weeks of treatment. This study is part of a registration directed program intended to obtain marketing approval of Probuphine for the treatment of opioid addiction in Europe and the United States.
Iloperidone
Iloperidone was evaluated in a Phase III program comprising over 3,500 patients at more than 200 sites in 24 countries, administered and funded by Novartis Pharma AG (Novartis). In three completed efficacy studies conducted by Novartis, ! i! loperidone statistically reduced the symptoms of schizophrenia compared to placebo. Iloperidone has also been investigated in three 12-month safety studies, which confirm safety and tolerability. A dose dependent increase in the Q-T Corrected (QTc) interval was observed and investigated further in a clinical study, and no clinically significant adverse events were observed. In September 2007, Vanda submitted a new drug application (NDA) with the United States Food and Drug Administration (FDA) for iloperidone. The NDA for iloperidone was officially accepted for review by the FDA in November 2007.
Spheramine
Spheramine is a cell-based therapeutic that utilizes the Company�� cell-coated microcarrier (CCM) technology, which enables the development of cell-based therapies for minimally invasive, site-specific delivery to the central nervous system of therapeutic factors precisely where they are needed. Spheramine consists of microcarriers coated wit h human retinal pigment epithelial cells that are intended to enhance brain levels of dopamine, a neurotransmitter deficient in certain brain regions in Parkinson�� disease, leading to movement disorders. Preclinical studies have demonstrated the preliminary efficacy and safety of Spheramine, including blinded studies in a primate model of Parkinson�� disease. In June 2007, enrollment was completed in a current multi-center, randomized, double-blind, placebo-controlled clinical trial of Spheramine in Parkinson�� disease. This Phase IIb clinical study enrolled 71 patients with advanced Parkinson�� disease (Hoehn and Yahr Stages III and IV) to further evaluate the efficacy, safety, and tolerability of Spheramine.
Bayer Schering, the Company�� corporate partner for worldwide development and commercialization of Spheramine, is funding the clinical development program for Spheramine. Under an agreement, Bayer Schering has received exclusive, worldwide deve lopment, manufacturing and commercialization rights, an! d, in! ad! dition! to the clinical and manufacturing development funding and milestone payments, Bayer Schering will pay Titan Pharmaceuticals a royalty on future product sales.
Advisors' Opinion:- [By C.R. Jackson]
Fanapt was discovered by Hoechst Marion Roussel in 1995 as a novel atypical antipsychotic agent. Hoechst was a German life-sciences company that became Aventis Deutschland after its merger with France's Rhône-Poulenc in 1999. When the company joined with Sanofi-Synthélabo in 2004, it became a subsidiary of the Sanofi-Aventis (SNY) the French pharmaceutical conglomerate. In 1997, Hoechst sold the research rights to Titan Pharmaceuticals (TTNP.OB). Then Titan quickly sold the worldwide rights to Novartis in 1998. Novartis then sold the Phase 3 development rights for loperidone to Vanda in 2004. Vanda originally attempted to get FDA approval for Fanapt in 2008, but the FDA refused to approve iloperidone. The agency required an additional clinical trial.
Top 10 Asian Companies To Buy For 2014: NTT DOCOMO Inc(DCM)
NTT DOCOMO, Inc. provides wireless telecommunications services, packet communications services, and satellite mobile communications services in Japan. It offers wireless voice and data communication services, such as second generation (2G) and third generation (3G) cellular services, and mobile multimedia services. The company provides mova services, on the 2G network, compatible with voice and data communication; FOMA services, on its 3G network, with voice and high-speed data communication, which are compatible with various services, such as videophone and video content downloading; and i-mode services, which are wireless Internet access services. As of March 31, 2010, it had approximately 56.08 million cellular subscribers. NTT DOCOMO also offers packet communications services, such as wireless data communications services using packet switching; satellite mobile communication services for communications in case of emergencies; and international calling and internationa l roaming services. In addition, the company provides mopera U Internet connection services for data cards and smartphones; embedded modules for automobile fleet management, wireless credit card settlement systems, and telemetric systems for automatic inventory checks between vending machines and service centers; and MyArea services that offer high-speed packet communication services for homes. Further, it offers home shopping services through TV media, high-speed Internet connection services for hotel facilities, advertisement services, and credit services, as well as develops, sells, and maintains IT systems. The company was formerly known as NTT Mobile Communications Network, Inc. and changed its name to NTT DOCOMO, Inc. in April 2000. NTT DOCOMO was founded in 1991 and is based in Tokyo, Japan. NTT DOCOMO, Inc. operates as a subsidiary of Nippon Telegraph and Telephone Corporation.
Advisors' Opinion:- [By Dan Carroll]
It was anything but a good week for Japanese telecom carrier NTT DoCoMo (NYSE: DCM ) , however. The wireless leader saw its stock fall 1.4% over the past five days even after reports emerged that Sony (NYSE: SNE ) could be releasing a new phone, the Xperia A, under DoCoMo's network. An FCC filing has shown the Xperia A with a 5-inch screen, and DoCoMo investors could know more when the company unveils its mobile offerings for the summer on May 15.
- [By Evan Niu, CFA]
That's not to say that Apple doesn't have opportunities there, but rather that the country isn't at the top of its priority list. Apple has never inked a deal with Japan's largest wireless carrier, NTT DoCoMo (NYSE: DCM ) , either. The top carrier currently has 61.6 million subscribers. Japan is actually one of the few countries where iOS has Android beat in market share. Kantar Worldpanel Comtech's first-quarter estimates peg iOS at 49.2%, with Android at 45.8%.
- [By gurujx]
NTT DoCoMo Inc (DCM) Reached the 52-Week High of $16.43
NTT DoCoMo Inc is a wireless telecommunications services provider. NTT DoCoMo Inc has a market cap of $68.13 billion; its shares were traded at around $16.43 with a P/E ratio of 14.00 and P/S ratio of 1.60. The dividend yield of NTT DoCoMo Inc stocks is 3.50%.
- [By Evan Niu, CFA]
Japan's top carrier NTT DoCoMo (NYSE: DCM ) has never offered Apple's (NASDAQ: AAPL ) iPhone, and that's not about to change anytime soon. NTT DoCoMo exec Kazuto Tsubouchi recently compared the device to DisneyLand, using the theme park as a comparison for a walled garden. The carrier would prefer to have more control over the experience, something that Apple isn't willing to give up.
Top 10 Asian Companies To Buy For 2014: International Montoro Resources Inc (IMT)
International Montoro Resources Inc. is engaged in the exploration and development of mineral properties, focusing on projects in British Columbia, Saskatchewan, and Ontario, Canada. The Company holds a 100% interest in the Malachite Project (New Brunswick). The Company holds a 50% interest in the Red Lake Project (Ontario), the Malachite property consists of 62 claim units comprising 1,352.25 hacteres. The Crackingstone River Project (Saskatchewan) consists of 750 hectare claim block in northern Saskatchewan near Uranium City. The Cup Lake/Donen Claims located in the Greenwood Mining District of B.C. On May 24, 2012, the Company acquired a 100% interest in four mineral claims representing 1,065.10 hactares, which were located in the middle of the west side of the Tacheeda Lake claim block. Advisors' Opinion:- [By Namitha Jagadeesh]
British American Tobacco Plc and Imperial Tobacco Group Plc (IMT) each lost at least 1.5 percent as American peer Philip Morris International Inc. forecast 2014 profit growth below its long-term target. Antofagasta Plc (ANTO) and Vedanta Resources Plc (VED) followed miners lower, sliding at least 2 percent. Johnson Matthey Plc (JMAT) gained 3.9 percent after posting better-than-forecast profit and raising its dividend.
Top 10 Asian Companies To Buy For 2014: O'Reilly Automotive Inc.(ORLY)
O?Reilly Automotive, Inc., together with its subsidiaries, engages in the retail of automotive aftermarket parts, tools, supplies, equipment, and accessories in the United States. The company?s stores provide new and remanufactured automotive hard parts, including alternators, starters, fuel pumps, water pumps, brake system components, batteries, belts, hoses, chassis parts, and engine parts; maintenance items comprising oil, antifreeze, fluids, filters, wiper blades, lighting, engine additives, and appearance products; and accessories, such as floor mats, seat covers, and truck accessories. Its stores also offer auto body paint and related materials, automotive tools, and professional service provider service equipment. The company?s stores sell its brand name and private label products for domestic and imported automobiles, vans, and trucks to do-it-yourself customers and professional service providers. As of March 31, 2011, it operated 3,613 stores. The company was foun ded in 1957 and is headquartered in Springfield, Missouri.
Advisors' Opinion:- [By Peter Graham]
The fiscal Q3 2014 earnings report for auto parts retailer stock AutoZone, Inc (NYSE: AZO), a peer of Advance Auto Parts, Inc (NYSE: AAP), O'Reilly Automotive Inc (NASDAQ: ORLY) and The Pep Boys - Manny, Moe & Jack (NYSE: PBY), is scheduled for before the market opens on Tuesday. Aside from the AutoZone earnings report, it should be said that Advance Auto Parts, Inc reported Q1 2014 earnings on May 15th (results were better than expected and they upped guidance); O'Reilly Automotive Inc reported Q1 2014 earnings on April 24th (results topped expectations); and The Pep Boys reported Q4 2013 earnings on April 15th and will report Q1 2014 earnings on June 10th (PBY reported a surprise loss as tire pricing negatively hit revenue). However and given the current uncertain economy that is keeping most consumers in their old cars, you would think that auto parts retailers in general would all be doing well.
- [By John Udovich]
Auto parts retailers like large cap O'Reilly Automotive Inc (NASDAQ: ORLY) and mid cap Advance Auto Parts, Inc (NYSE: AAP)�along with small cap auto parts stock Federal-Mogul Corp (NASDAQ: FDML) have been a bright spot on the economy as consumers try to stretch the lives of their automobiles or vehicles in the bad or uncertain economy. In fact, Investors Business Daily has recently noted that the�average age of cars on the road is about 11.5 years and that�� of course good news for auto parts retailers while�any uptick in sales or production of auto parts in general�will be good for companies like Federal-Mogul Corp. With that in mind, here�is a look at�how these three auto parts retailers or auto parts stocks are taking investors for a ride in a good way:
- [By Ben Levisohn]
Autozone has dropped 0.3% to $413.22 �, while�Pep Boys (PBY) has gained 0.2% to $12.19 , Advanced Auto Parts�(AAP) has risen 0.3% to $80.35, and O’Reilly Automotive (ORLY) has advanced 0.3% to $124.42 .
Top 10 Asian Companies To Buy For 2014: Tree.com Inc.(TREE)
Tree.Com, Inc., through its subsidiaries, engages in lending business in the United States. It owns various brands and businesses that provide information, tools, advice, products, and services for consumers looking to comparison shop for loans, real estate, and other services from businesses and professionals. The company?s LendingTree Loans segment originates, processes, approves, and funds various types of residential real estate loans primarily under the LendingTree Loans brand name. It offers a range of adjustable and fixed rate mortgage loans, including conforming and prime loans, as well as non-conforming and FHA loans. This segment sources its leads through online and telephone services, as well as through various non-LendingTree channels, such as third-party online lead aggregators and direct mail marketing campaigns. Its Exchanges segment consists of online lead generation networks under the LendingTree.com, GetSmart.com, DegreeTree.com, HealthTree.com, LendingT reeAutos.com, DoneRight.com, and InsuranceTree.com brands; and call centers that connect consumers and service providers, principally in the lending, higher education, home services, insurance, and automobile marketplaces. This segment also provides unsecured loans, automobile loans, credit cards, and various consumer insurance products, as well as opportunities for students seeking institutions of higher education, and home improvement professional services with contractors. The company is based in Charlotte, North Carolina.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
Casper1774 Studio/Shutterstock You may not have noticed it, but recently, it's gotten easier to buy a new home. Last year, a strong housing market combined with fears that the Federal Reserve would eventually begin tapering its purchases of mortgage bonds. Together, these factors helped drive up the cost of a 30-year fixed-rate mortgage from about 3.3 percent in January 2013 to nearly 4.6 percent by September. Since then, mortgage rates have backed off those recent highs, bobbling back and forth between 4.5 percent or so, and, recently, 4.2 percent. This has helped to keep housing affordable for those who want to buy a home. But it did pose the bankers a dilemma: How could they get more people to want to buy homes in the first place, so that they could sell more mortgages? Answer: Make it easier to apply for a mortgage. Mortgage Down Payments Live Down to Their Name Last spring, lending data website LendingTree.com (TREE) released a report showing that the average down payment demanded by mortgage bankers to obtain a 30-year fixed-rate mortgage had fallen 9.4 percent since mid-2011. At 16.1 percent, it was nearly 4 full percentage points shy of the old rule of thumb that a home buyer should put 20 percent down on a new home. Six months later, average down payments had fallen to 15.73 percent of the value of a home. Now, LendingTree has put out an updated report showing that after down payment demands inched back up in 2013 (to 16.01 percent), they've begun to fall once more. At last report, mortgage bankers on average want to see a 15.78 percent down payment -- a bit more than what we saw last fall, but still continuing the downward trend in down payments. Why? One clue may be found in recent comments from Freddie Mac vice president and chief economist Frank Nothaft, who's been highlighting declines in existing-home sales, in new-home sales as well, and even in permits taken out to build houses, in a series of reports through April. If home-buying is
Top 10 Asian Companies To Buy For 2014: BlackRock Enhanced Capital And Income Fund Inc (CII)
BlackRock Enhanced Capital and Income Fund, Inc. (the Fund), formerly BlackRock Capital and Income Strategies Fund, Inc., is a diversified, closed-end management investment company. The Fund seeks to provide current income and capital appreciation. It invests in a portfolio of equity and debt securities of United States and foreign issuers. The Fund�� portfolio includes common stocks, preferred stocks, foreign government obligations, corporate bonds, trust preferreds and municipal bonds. The Fund employs a strategy of writing (selling) call options on equity indexes in an attempt to generate gains from option premiums (the Index Option Strategy). Under the Index Option Strategy, the Fund will write call options primarily on the S&P 500 Index, but may, from time to time, write call options on other equity indexes as well. The Fund�� investment advisor is BlackRock Advisors, LLC, an indirect, wholly owned subsidiary of BlackRock, Inc.
The Fund invests in various industries, including commercial banks, diversified financial services, electric utilities, food products, gas utilities, insurance, thrifts and mortgage finance, and real estate investment trusts. On September 29, 2006, BlackRock, Inc. and Merrill Lynch & Co., Inc. (Merrill Lynch) combined Merrill Lynch�� investment management business, Merrill Lynch Investment Managers, L.P. (MLIM), and its affiliates, including Fund Asset Management, L.P. (FAM), with BlackRock, Inc. to create an independent company. Merrill Lynch has a 49.8% economic interest and a 45% voting interest in the combined company, and The PNC Financial Services Group, Inc. (PNC) has approximately a 34% economic and voting interest. The new company operates under the BlackRock name.
Advisors' Opinion:- [By Dividends4Life]
According to a Gabelli Funds report, managed distribution policies offer several advantages, including:1. Lower difference between the fund�� market price and its NAV per share.2. Provides support during periods when the stock market is in a decline.3. Provides a measurable performance target for the investment adviser.Below are several high-yield funds from CEFA that have a managed distribution policy (yields as of December 16):Aberdeen Australia Eqty (IAF)- Distribution Yield: 10.4%- Income Yield: 3.46%Bexil Advisers LLC� (DNI)- Distribution Yield: 11.1%- Income Yield: 3.56%BlackRock En Capital&Inc (CII)- Distribution Yield: 8.78%- Income Yield: 2.34%Cornerstone Strat Value (CLM)- Distribution Yield: 18.77%- Income Yield: 1.83%Cornerstone Total Return (CRF)- Distribution Yield: 19.10%- Income Yield: 0.85%Delaware Inv Div & Inc (DDF)- Distribution Yield: 6.70%- Income Yield: 5.26%Gabelli Equity Trust (GAB)- Distribution Yield: 7.58%- Income Yield: 1.54%Gabelli Utility Trust (GUT)- Distribution Yield: 9.45%- Income Yield: 2.84%MFS Special Value Trust (MFV)- Distribution Yield: 9.60%- Income Yield: 5.73%Nuveen Tx-Adv TR Strat (JTA)- Distribution Yield: 6.70%- Income Yield: 3.12%TCW Strategic Income (TSI)- Distribution Yield: 10.54%- Income Yield: 7.88%Zweig Total Return (ZTR)- Distribution Yield: 7.27%- Income Yield: 1.95%As noted in the Gabelli report, a managed distribution policy may create confusion regarding the true current yield since the reported yield includes the return of capital portion. You can see the disparity above between the income yield and the distribution (reported) yield.If you are looking for a sustainable and growing dividend, you may want to consider some blue-chip dividend stocks such as these with a Free Cash Flow Payout less than 50%, 50+ years of consecutive dividend increases and a 2%+ yield:3M Co. (MMM) is a diversified global company provides enhanced product functionality in electronics, health care, industrial, consumer
No comments:
Post a Comment